BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

823 related articles for article (PubMed ID: 17784892)

  • 1. Intravenous and intranasal heroin-dependent treatment-seekers: characteristics and treatment outcome.
    Highfield DA; Schwartz RP; Jaffe JH; O'Grady KE
    Addiction; 2007 Nov; 102(11):1816-23. PubMed ID: 17784892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized controlled trial of interim methadone maintenance.
    Schwartz RP; Highfield DA; Jaffe JH; Brady JV; Butler CB; Rouse CO; Callaman JM; O'Grady KE; Battjes RJ
    Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.
    Vigezzi P; Guglielmino L; Marzorati P; Silenzio R; De Chiara M; Corrado F; Cocchi L; Cozzolino E
    J Subst Abuse Treat; 2006 Jul; 31(1):3-7. PubMed ID: 16814005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Topping up' methadone: an analysis of patterns of heroin use among a treatment sample of Scottish drug users.
    Bloor M; McIntosh J; McKeganey N; Robertson M
    Public Health; 2008 Oct; 122(10):1013-9. PubMed ID: 18490036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled trial of interim methadone maintenance: 10-Month follow-up.
    Schwartz RP; Jaffe JH; Highfield DA; Callaman JM; O'Grady KE
    Drug Alcohol Depend; 2007 Jan; 86(1):30-6. PubMed ID: 16793221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled trial of prescribed heroin in the treatment of opioid addiction.
    March JC; Oviedo-Joekes E; Perea-Milla E; Carrasco F;
    J Subst Abuse Treat; 2006 Sep; 31(2):203-11. PubMed ID: 16919749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-treatment vs. out-of-treatment opioid dependent adults: drug use and criminal history.
    Schwartz RP; Kelly SM; O'Grady KE; Peterson JA; Reisinger HS; Mitchell SG; Wilson ME; Agar MH; Brown BS
    Am J Drug Alcohol Abuse; 2008; 34(1):17-28. PubMed ID: 18161640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of heroin-assisted treatment in Germany.
    Verthein U; Bonorden-Kleij K; Degkwitz P; Dilg C; Köhler WK; Passie T; Soyka M; Tanger S; Vogel M; Haasen C
    Addiction; 2008 Jun; 103(6):960-6; discussion 967-8. PubMed ID: 18422829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of baseline cocaine use on treatment outcomes for heroin dependence over 24 months: findings from the Australian Treatment Outcome Study.
    Williamson A; Darke S; Ross J; Teesson M
    J Subst Abuse Treat; 2007 Oct; 33(3):287-93. PubMed ID: 17889301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matching of treatment-resistant heroin-dependent patients to medical prescription of heroin or oral methadone treatment: results from two randomized controlled trials.
    Blanken P; Hendriks VM; Koeter MW; van Ree JM; van den Brink W
    Addiction; 2005 Jan; 100(1):89-95. PubMed ID: 15598196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time series modeling of heroin and morphine drug action.
    Tschacher W; Haemmig R; Jacobshagen N
    Psychopharmacology (Berl); 2003 Jan; 165(2):188-93. PubMed ID: 12404073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid negative feedback in methadone-maintained former heroin addicts with ongoing cocaine dependence: dose-response to dexamethasone suppression.
    Aouizerate B; Ho A; Schluger JH; Perret G; Borg L; Le Moal M; Piazza PV; Kreek MJ
    Addict Biol; 2006 Mar; 11(1):84-96. PubMed ID: 16759341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
    Ngo HT; Tait RJ; Hulse GK
    Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life among heroin users on buprenorphine versus methadone maintenance.
    Ponizovsky AM; Grinshpoon A
    Am J Drug Alcohol Abuse; 2007; 33(5):631-42. PubMed ID: 17891656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of long-term heroin-assisted treatment offered to chronic, treatment-resistant heroin addicts in the Netherlands.
    Blanken P; Hendriks VM; van Ree JM; van den Brink W
    Addiction; 2010 Feb; 105(2):300-8. PubMed ID: 19922517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between cocaine use and short-term outcomes for the treatment of heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
    Williamson A; Darke S; Ross J; Teesson M
    Drug Alcohol Rev; 2006 Mar; 25(2):141-8. PubMed ID: 16627303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Key Extended Entry Program (KEEP): from the community side of the bridge.
    Fallon BM
    Mt Sinai J Med; 2001 Jan; 68(1):21-7. PubMed ID: 11135502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of heroin, cocaine, and alcohol abuse during long-term methadone maintenance treatment.
    Dobler-Mikola A; Hättenschwiler J; Meili D; Beck T; Böni E; Modestin J
    J Subst Abuse Treat; 2005 Dec; 29(4):259-65. PubMed ID: 16311178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS).
    Ross J; Teesson M; Darke S; Lynskey M; Ali R; Ritter A; Cooke R
    Drug Alcohol Rev; 2005 Sep; 24(5):411-8. PubMed ID: 16298835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.